- Home
- LVRO vs RNAC Comparison
LVRO vs RNAC Comparison
Compare LVRO & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVRO
- RNAC
- Stock Information
- Founded
- LVRO 2017
- RNAC 2007
- Country
- LVRO Brazil
- RNAC United States
- Employees
- LVRO N/A
- RNAC N/A
- Industry
- LVRO Blank Checks
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- LVRO Finance
- RNAC Health Care
- Exchange
- LVRO Nasdaq
- RNAC Nasdaq
- Market Cap
- LVRO 387.1M
- RNAC 428.2M
- IPO Year
- LVRO N/A
- RNAC 2016
- Fundamental
- Price
- LVRO $3.25
- RNAC $19.85
- Analyst Decision
- LVRO Strong Buy
- RNAC Strong Buy
- Analyst Count
- LVRO 3
- RNAC 8
- Target Price
- LVRO $6.83
- RNAC $41.67
- AVG Volume (30 Days)
- LVRO 14.3K
- RNAC 128.4K
- Earning Date
- LVRO 03-06-2025
- RNAC 03-06-2025
- Dividend Yield
- LVRO N/A
- RNAC N/A
- EPS Growth
- LVRO N/A
- RNAC N/A
- EPS
- LVRO N/A
- RNAC N/A
- Revenue
- LVRO $1,691,812,087.00
- RNAC $47,938,000.00
- Revenue This Year
- LVRO N/A
- RNAC $56.02
- Revenue Next Year
- LVRO $12.53
- RNAC N/A
- P/E Ratio
- LVRO N/A
- RNAC N/A
- Revenue Growth
- LVRO 0.48
- RNAC N/A
- 52 Week Low
- LVRO $3.06
- RNAC $11.67
- 52 Week High
- LVRO $8.33
- RNAC $41.87
- Technical
- Relative Strength Index (RSI)
- LVRO 27.62
- RNAC 55.84
- Support Level
- LVRO $3.06
- RNAC $18.27
- Resistance Level
- LVRO $3.97
- RNAC $20.12
- Average True Range (ATR)
- LVRO 0.44
- RNAC 1.23
- MACD
- LVRO -0.16
- RNAC 0.27
- Stochastic Oscillator
- LVRO 7.48
- RNAC 92.74
About LVRO Lavoro Limited
Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.